- GP practice
Dr JI Solomon's Practice
Assessment report published 9 July 2026
Contents
On this page
- Overview
- Learning culture
- Safe systems, pathways and transitions
- Safeguarding
- Involving people to manage risks
- Safe environments
- Safe and effective staffing
- Infection prevention and control
- Medicines optimisation
Safe
We looked for evidence that people were protected from abuse and avoidable harm.
At our last assessment in July 2025, we rated this key question as Requires Improvement. At this assessment in April 2026, the rating has changed to Good.
This service scored 72 (out of 100) for this area. Find out what we look at when we assess this area and How we calculate these scores.
Learning culture
We did not look at Learning culture during this assessment. The score for this quality statement is based on the previous rating for Safe.
Safe systems, pathways and transitions
We did not look at Safe systems, pathways and transitions during this assessment. The score for this quality statement is based on the previous rating for Safe.
Safeguarding
We did not look at Safeguarding during this assessment. The score for this quality statement is based on the previous rating for Safe.
Involving people to manage risks
We did not look at Involving people to manage risks during this assessment. The score for this quality statement is based on the previous rating for Safe.
Safe environments
We did not look at Safe environments during this assessment. The score for this quality statement is based on the previous rating for Safe.
Safe and effective staffing
We did not look at Safe and effective staffing during this assessment. The score for this quality statement is based on the previous rating for Safe.
Infection prevention and control
The service assessed and managed the risk of infection. They detected and controlled the risk of it spreading and shared concerns with appropriate agencies promptly.
At the comprehensive assessment in July 2025, we identified that improvements were needed to some fixtures and fittings to meet infection prevention and control (IPC) guidelines, including replacing carpets in consulting rooms, fabric chairs in the waiting area, repairing wall cracks, and upgrading hand wash basins and taps in clinical rooms.
At this assessment, we noted the provider had made progress in mitigating some risks associated with IPC. This included replacing waiting room chairs with wipeable alternatives, repairing wall and ceiling cracks in non-patient areas, making improvements to some hand wash facilities, and providing refresher IPC training for the practice nurse and practice manager.
An external IPC audit was completed in October 2025; however, it did not provide sufficient detail on non-compliant clinical areas to meet IPC guidelines. Specifically, this related to the presence of carpets in consulting rooms (1 of which we were informed was not in clinical use) and the remaining non-compliant hand wash basins in clinical rooms. The provider had however identified these areas for improvement and recorded them in a risk register. They intended to address them through a planned refurbishment, for which funding was anticipated.
Medicines optimisation
The service made sure that medicines and treatments were safe and met people’s needs, capacities, and preferences. They involved people in planning, including when changes happened.
At the comprehensive assessment in July 2025, our clinical review identified improvements were required to ensure clinicians were prescribing safely. The service were responsive to mitigate potential risks we had identified, however these systems required embedding to ensure they were effective.
At this assessment in March – April 2026, we found that systems in place to support the safe and effective management of medicines had improved:
- Patients prescribed methotrexate, a Disease Modifying Antirheumatic Drug (DMARD) used to treat autoimmune conditions, had appropriate blood monitoring prior to a prescription being issued.
- In line with a safety alert, patients of child bearing potential were informed of the risks associated with medicines that may cause harm to an unborn baby.
- Patients prescribed medicines for neuropathic pain, epilepsy, and anxiety had their response to treatment and dosage reviewed within the last 12 months.
- There had been an improvement in the monitoring of patients prescribed medicines that required regular monitoring. However, in 2 of the 5 patient records reviewed, monitoring was not up to date despite the service having made multiple attempts to engage with these individuals. During the assessment, the service took appropriate action. This included undertaking a clinical review, changing one patient’s medication following a discussion with them, and reducing prescribing quantities for another patient pending completion of the required blood tests to support safe ongoing treatment.
Leaders informed us that clinical pharmacists assigned to the practice through the primary care network (PCN) were now in post on a full-time basis, rather than rotating every three months. This had improved continuity, supporting more consistent communication and the development of effective protocols. The service had also introduced in-house phlebotomy provision through ARRS (Additional Roles Reimbursement Scheme) staff, which had improved patient access to routine blood test monitoring.
Staff involved people in reviews of their medicines and helped them understand how to manage their medicines safely. Staff received regular training, were competency assessed on medicines optimisation, and felt confident managing the storage, administration and recording of medicines. Staff managed prescription stationery appropriately and securely. Staff followed protocols to ensure they prescribed all medicines safely, and ensured people received all recommended medicines reviews and monitoring.
Medicines were stored securely and at appropriate temperatures. We noted that the second fridge thermometers were not working. The service was aware of this and awaiting replacement batteries, and subsequently provided evidence once this had been resolved. Staff regularly checked the stock levels and expiry dates for all medicines, including emergency medicines and vaccines. Staff stored medical gases, such as oxygen, safely and completed required safety risk assessments. The provider had effective systems to manage and respond to safety alerts and medicine recalls. Staff followed established processes to ensure people prescribed medicines with specific risks received recommended monitoring.
Staff took steps to ensure they prescribed medicines appropriately to optimise care outcomes, including antibiotics. Prescribing data reviewed as part of our assessment confirmed this. For example, the number of antimicrobials issued by the provider was lower than national averages, indicating good prescribing practice. There was a programme of regular clinical audits of prescribing that focused on improving care and treatment.